Tag Archives: Lung Cancer
Progress and technological advancement in the field of medical science have created several opportunities in the field of oncology and oncology drugs.
Chennai: Global Hospitals on Saturday inaugurated the country’s first wide-bore 3T Silent Scan MRI with MAGiC, which can reportedly reduce scan time by as much as 67%, at its hospital in Perumbakkam, Chennai. The hospital also inaugurated GE Healthcare’s Discovery IQ PET/CT system that can assist in diagnosis, staging and post treatment monitoring of cancer.
Singapore: A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer. Published in Nature Communications, the findings provide fresh insight into understanding therapy resistance in lung cancer and unveil new avenues to monitor and treat the disease more effectively.
Washington: In experimental models of lung cancer, researchers have found that a combination of two drugs plus radiation can help treat resistant lung cancers which are susceptible to therapy.
It really worries me to see the sorry state of tobacco consumption in our country. It inflicts huge damage on the health of Indians and could be clocking up a death toll of 1.5 million a year by 2020 if more users are not persuaded to kick the habit.
New York: A new radiation therapy, which has already been in use to treat prostate, brain, and head and neck cancers, also reduces chemotherapy side effects when administered in those afflicted with lung cancer, new research has found.
Washington: The US Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.
Washington: The US Food and Drug Administration on Friday granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumours that express a protein called PD-L1.
London: Combining chemotherapy with new drugs that target a protein that helps cancer cells to withstand chemotherapy could drastically improve treatment, according to research published in the journal Cancer Cell.
FDA approves targeted therapy for first-line treatment of patients with a type of metastatic lung cancer
Washington: The US Food and Drug Administration has approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours harbour specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.